111 related articles for article (PubMed ID: 26952438)
1. Capillary microfluidics-derived doxorubicin-containing human serum albumin microbeads for transarterial chemoembolization of hepatic cancer.
Kim MK; Kim MA; Jenjob R; Lee DH; Yang SG
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():391-7. PubMed ID: 26952438
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats.
Di Stefano G; Fiume L; Baglioni M; Busi C; Bolondi L; Farina C; Mori F; Chieco P; Pariali M; Kratz F; Molin L; Salmaso S; Caliceti P
Eur J Pharm Sci; 2008 Feb; 33(2):191-8. PubMed ID: 18201877
[TBL] [Abstract][Full Text] [Related]
3. Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin.
Di Stefano G; Fiume L; Baglioni M; Busi C; Chieco P; Kratz F; Mattioli A
Eur J Pharm Sci; 2007 Feb; 30(2):136-42. PubMed ID: 17218086
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-loaded poly(lactic-co-glycolic acid) microspheres prepared using the solid-in-oil-in-water method for the transarterial chemoembolization of a liver tumor.
Choi JW; Park JH; Baek SY; Kim DD; Kim HC; Cho HJ
Colloids Surf B Biointerfaces; 2015 Aug; 132():305-12. PubMed ID: 26057730
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of combination therapy schedules of doxorubicin and an acid-sensitive albumin-binding prodrug of doxorubicin in the MIA PaCa-2 pancreatic xenograft model.
Kratz F; Azab S; Zeisig R; Fichtner I; Warnecke A
Int J Pharm; 2013 Jan; 441(1-2):499-506. PubMed ID: 23149257
[TBL] [Abstract][Full Text] [Related]
6. Development of albumin-binding doxorubicin prodrugs that are cleaved by prostate-specific antigen.
Kratz F; Mansour A; Soltau J; Warnecke A; Fichtner I; Unger C; Drevs J
Arch Pharm (Weinheim); 2005 Oct; 338(10):462-72. PubMed ID: 16211657
[TBL] [Abstract][Full Text] [Related]
7. Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH), an albumin-binding prodrug of the anticancer agent doxorubicin.
Kratz F; Ehling G; Kauffmann HM; Unger C
Hum Exp Toxicol; 2007 Jan; 26(1):19-35. PubMed ID: 17334177
[TBL] [Abstract][Full Text] [Related]
8. Single-bolus regional chemotherapy with doxorubicin versus chemoembolization in a rabbit VX2 tumor model.
Cho SK; Shin SW; Do YS; Jang KT; Choo SW; Park KB; Park HS; Chang IS
Diagn Interv Radiol; 2011 Dec; 17(4):374-80. PubMed ID: 21225581
[TBL] [Abstract][Full Text] [Related]
9. Liver-targeted doxorubicin: effects on rat regenerating hepatocytes.
Di Stefano G; Derenzini M; Kratz F; Lanza M; Fiume L
Liver Int; 2004 Jun; 24(3):246-52. PubMed ID: 15189276
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
[TBL] [Abstract][Full Text] [Related]
11. A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentiation grade.
Di Stefano G; Fiume L; Baglioni M; Bolondi L; Busi C; Chieco P; Kratz F; Manaresi F; Pariali M
Liver Int; 2006 Aug; 26(6):726-33. PubMed ID: 16842330
[TBL] [Abstract][Full Text] [Related]
12. Preparation of doxorubicin-containing chitosan microspheres for transcatheter arterial chemoembolization of hepatocellular carcinoma.
Kim JS; Kwak BK; Shim HJ; Lee YC; Baik HW; Lee MJ; Han SM; Son SH; Kim YB; Tokura S; Lee BM
J Microencapsul; 2007 Aug; 24(5):408-19. PubMed ID: 17578731
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine.
Fiume L; Bolondi L; Busi C; Chieco P; Kratz F; Lanza M; Mattioli A; Di Stefano G
J Hepatol; 2005 Oct; 43(4):645-52. PubMed ID: 16023760
[TBL] [Abstract][Full Text] [Related]
14. Sprague-Dawley rats bearing McA-RH7777 cells for study of hepatoma and transarterial chemoembolization.
Cho HR; Choi JW; Kim HC; Song YS; Kim GM; Son KR; Chung JW
Anticancer Res; 2013 Jan; 33(1):223-30. PubMed ID: 23267149
[TBL] [Abstract][Full Text] [Related]
15. Toxicity of doxorubicin on pig liver after chemoembolization with doxorubicin-loaded microspheres: a pilot DNA-microarrays and histology study.
Verret V; Namur J; Ghegediban SH; Wassef M; Moine L; Bonneau M; Pelage JP; Laurent A
Cardiovasc Intervent Radiol; 2013 Feb; 36(1):204-12. PubMed ID: 22441757
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma].
Ferrer Puchol MD; la Parra C; Esteban E; Vaño M; Forment M; Vera A; Cosín O
Radiologia; 2011; 53(3):246-53. PubMed ID: 21295802
[TBL] [Abstract][Full Text] [Related]
17. Highly Tumor-Specific and Long-Acting Iodine-131 Microbeads for Enhanced Treatment of Hepatocellular Carcinoma with Low-Dose Radio-Chemoembolization.
Qian Y; Liu Q; Li P; Han Y; Zhang J; Xu J; Sun J; Wu A; Song S; Lu W
ACS Nano; 2021 Feb; 15(2):2933-2946. PubMed ID: 33529007
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and antitumor efficacy of chemoembolization using 40 µm irinotecan-loaded microspheres in a rabbit liver tumor model.
Tanaka T; Nishiofuku H; Hukuoka Y; Sato T; Masada T; Takano M; Gilbert CW; Obayashi C; Kichikawa K
J Vasc Interv Radiol; 2014 Jul; 25(7):1037-1044.e2. PubMed ID: 24861663
[TBL] [Abstract][Full Text] [Related]
19. Drug-loaded microspheres for the treatment of liver cancer: review of current results.
Kettenbach J; Stadler A; Katzler IV; Schernthaner R; Blum M; Lammer J; Rand T
Cardiovasc Intervent Radiol; 2008; 31(3):468-76. PubMed ID: 18228095
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]